Table 3.
Without adverse neonatal outcomes (n = 20) | With adverse neonatal outcomes (n = 25) | P value | |
---|---|---|---|
Mean glucose (mg/dL) | 107 [92-120] | 118 [106-129] | .049 |
Total TAR (>140) (%) | 10 [4-23] | 26 [12-32] | .018 |
TAR1 (140-180) (%) | 9 [4-20] | 16 [9-22] | .090 |
TAR2 (>180) (%) | 1 [0-4] | 6 [2-15] | .004 |
TIR (63-140) (%) | 88 [75-92] | 71 [64-83] | .007 |
Total TBR (<63) (%) | 3 [0.3-6] | 1 [0-5] | .921 |
TBR1 (63-54) (%) | 2 [0-4] | 1 [0-5] | .969 |
TBR2 (<54) (%) | 0 [0-1] | 0 [0-1] | .740 |
pGRI (%) | 18 [10-31] | 38 [18-49] | .013 |
GMI (mmol/mol) | 40 [37-43] | 43 [40-46] | .046 |
CV (%) | 24 [20-28] | 30 [25-35] | .009 |
TDD/kg (UI/lg) | 0.5 [0.2-0.9] | 0.8 [0.7-1.2] | .070 |
Weight gain (kg) | 10 [8-14] | 13 [9-15] | .609 |
HbA1c (%) | 5.7 [5.5-6.7] | 5.8 [5.5-6.4] | .536 |
Among preterm delivery, macrosomia, large for gestational age, small for gestational age, neonatal hypoglycemia, neonatal jaundice, neonatal intensive care unit admission.
Data are expressed as median [interquartile range].
Abbreviations: TAR, time above range; TIR, time in range; TBR, time below range; pGRI, pregnancy-specific Glycemic Risk Index; GMI: glucose management indicator; CV, coefficient of variation; TDD, total daily insulin dose.